Johnson & Johnson (NYSE:JNJ) is recalling two of its popular drugs from the market citing insufficiencies in the manufacturing process. The recall is being made for more than 4 million packages of junior strength Motrin and children’s Benadryl Allergy tablets.
The recall is only for the current stock which has only reached wholesalers and retailers. Hence the customers who have the medicine already purchased a week before can safely use them. The recalled medicines do not have any heath safety concerns. There was no immediate effect on the shares of Johnson & Johnson (NYSE:JNJ) due to these recalls.
Related posts:
- Finding The Source of HIV
- Theraputic Discovery Grant Awarded to Affymax
- GSK Gets Green Light For Lupus
- Wal-Mart’s Success with Prescription Plan
- Jane Fonda Confirms breast Cancer
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.